Product Information
TORSEMIDE 5 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.0573 per EA under NDC 23155087101. Its NADAC has been published 143 times since Jan 10, 2024.
FDA first approved this application on May 31, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155087101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TORSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076894FDA Approved
5/31/2005
TE Code
AB
On Market Since
7/24/2023
Pharmacological Classes
Price Statistics
The NADAC for TORSEMIDE 5 MG TABLET has been published 143 times since Jan 10, 2024, and over the history we have for it it has declined 31.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0573 per EA |
|---|---|
| All-time high | $0.0854 (Feb 14, 2024) |
| All-time low | $0.0573 (Sep 23, 2026) |
| 52-week high | $0.0677 |
| 52-week low | $0.0573 |
| Median price | $0.0651 |
| Average price | $0.0676 |
| Largest weekly change | -21.0% (Apr 17, 2024) |
| Weeks tracked | 143 |
| Tracking since | Jan 10, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Torsemide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TORSEMIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TORSEMIDE 5 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.0573 per EA (NDC 23155087101), effective Sep 30, 2026.
How has the price of TORSEMIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TORSEMIDE 5 MG TABLET has declined 31.2%. It has been tracked across 143 weekly CMS publications since Jan 10, 2024.
What are the highest and lowest recorded NADAC prices for TORSEMIDE 5 MG TABLET?
Since Jan 10, 2024, the NADAC for TORSEMIDE 5 MG TABLET has ranged from a low of $0.0573 (Sep 23, 2026) to a high of $0.0854 (Feb 14, 2024), with a median of $0.0651 per EA.
Are there cheaper alternatives to TORSEMIDE 5 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TORSEMIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TORSEMIDE 5 MG TABLET?
TORSEMIDE 5 MG TABLET (NDC 23155087101) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.